Human Immunodeficiency Virus Type 1 (HIV-1) Infection a Median of 18 Months before a Diagnostic Western Blot
- 15 December 1989
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 111 (12) , 961-972
- https://doi.org/10.7326/0003-4819-111-12-961
Abstract
To study the natural history of human immunodeficiency virus type 1 (HIV-1) infection, we used an in-vitro amplification technique to detect HIV-1 nucleic acid sequences in sequential aliquots of peripheral blood mononuclear cells from homosexual men enrolled in the Multicenter AIDS Cohort Study. A blinded, longitudinal study of 24 homosexual men who were positive for HIV-1 antibodies at a recent follow-up visit was conducted. Coded clinical samples were evaluated using two ELISA (whole virus and gp120-gp41 fragment), Western blot, a p24 antigen capture assay, virus cocultivation, and in-vitro amplification of conserved regions from the HIV-1 gag and env open-reading frames. In 20 of the 24 men an HIV-1 enzymatically amplified product was detected before HIV-1 antibody seroconversion: at 42 months before seroconversion in two cases; at 36 months in one case; at 30 months in one case; at 24 months in four cases; at 18 months in eight cases; at 12 months in one case; and at 6 months in three cases (median, 18 months). In the four other men, detection of an HIV-1 enzymatically amplified product was concurrent with conformation of antibody seroconversion by Western blot. There is a long and variable interval between virus acquisition and a diagnostic serum antibody response, perhaps due to the prolonged, persistent infection characteristics of the lentiviruses (family Retroviridae).Keywords
This publication has 40 references indexed in Scilit:
- Genetic Variation in HTLV-III/LAV Over Time in Patients with AIDS or at Risk for AIDSScience, 1986
- Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization.Proceedings of the National Academy of Sciences, 1986
- Human T-Lymphotropic Virus Type III in High-Risk, Antibody-Negative Homosexual MenAnnals of Internal Medicine, 1986
- Primary Human T-Lymphotropic Virus Type III InfectionAnnals of Internal Medicine, 1985
- Exposure to Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus and Immunologic Abnormalities in Asymptomatic Homosexual MenAnnals of Internal Medicine, 1985
- ACUTE AIDS RETROVIRUS INFECTIONThe Lancet, 1985
- HTLV-III IN SYMPTOM-FREE SERONEGATIVE PERSONSThe Lancet, 1984
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983